Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Others
    (2)
TargetMol | Tags By ResearchField
  • Cancer
    (2)
  • Immune System
    (1)
TargetMol | Tags By Application
  • ELISA
    (2)
  • Functional assay
    (2)
  • FACS
    (1)
  • FCM
    (1)
Filter
Search Result
Results for "

anti-slamf7

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    2
    TargetMol | All_Pathways
  • Inhibitory Antibodies
    2
    TargetMol | Inhibitory_Antibodies
  • Antibody Products
    7
    TargetMol | Antibody_Products
  • Elotuzumab
    PDL 063, HuLuc 63, Elotuzumab (anti-SLAMF7), BMS 901608
    T35386915296-00-3
    Elotuzumab(HuLuc 63) is a monoclonal antibody that targets the SLAMF7 receptor.Elotuzumab is a compound that directly activates NK cells and induces antibody-dependent cytotoxicity, and can be used in combination with lenalidomide and dexamethasone (Ld) to treat multiple myeloma.
    • $228
    In Stock
    Size
    QTY
  • PDL-241
    T9901A-1424
    PDL-241 is a humanized monoclonal antibody targeting SLAMF7 (also known as CD319 or CS1), which is highly expressed on multiple myeloma cells and natural killer (NK) cells. It exerts anti-tumor effects by directly inducing apoptosis, mediating ADCC effects, and boosting anti-tumor immunity through NK cell activation, making it widely used in research on targeted therapies for hematological malignancies.
    • $318
    12 days
    Size
    QTY